Pages with the fewest revisions
Appearance
Showing below up to 50 results in range #651 to #700.
- Hydroquinone (2 revisions)
- Effect:Peripheral information misinterpretation (2 revisions)
- Effect:Confusion (2 revisions)
- Methimazole (2 revisions)
- Effect:Frame rate enhancement (2 revisions)
- Effect:Mindfulness (2 revisions)
- Phenotype:TPMT intermediate metabolizer (2 revisions)
- Rivaroxaban (2 revisions)
- Effect:Constipation (2 revisions)
- Phenotype:CYP2D6 intermediate metabolizer (2 revisions)
- Lactulose (2 revisions)
- Effect:Seizure/Epileptic fit (2 revisions)
- Problem:Narcolepsy (2 revisions)
- Labetalol (2 revisions)
- Effect:Time distortion (2 revisions)
- Problem:Anorexia Nervosa (2 revisions)
- Effect:Vibrating vision (2 revisions)
- Problem:Diarrhea (2 revisions)
- Tretinoin (2 revisions)
- Effect:Physical autonomy (2 revisions)
- Problem:Social Anxiety Disorder (2 revisions)
- Verapamil (2 revisions)
- Effect:Texture liquidation (2 revisions)
- Problem:Bipolar Affective Disorder (2 revisions)
- Colchicine (2 revisions)
- Effect:Anterograde amnesia (2 revisions)
- Problem:Schizoid Personality Disorder (2 revisions)
- Brexanolone (2 revisions)
- Effect:Cognitive impairment (2 revisions)
- Problem:Schizotypal Personality Disorder (2 revisions)
- Effect:Creativity enhancement (2 revisions)
- Problem:Nicotine dependence (2 revisions)
- Riboflavin (2 revisions)
- Loratadine (2 revisions)
- Effect:Increased introspection (2 revisions)
- Problem:Specific Learning Disorder with Dyslexia (2 revisions)
- Albuterol (2 revisions)
- Effect:Olfactory intensification (2 revisions)
- Problem:Neuropathic pain (2 revisions)
- Rosuvastatin (2 revisions)
- Effect:Dosage independent intensity (2 revisions)
- Problem:Cancer-Related Distress (2 revisions)
- Doxazosin (2 revisions)
- TiHKAL (2 revisions)
- Effect:Neuroleptic malignant syndrome (2 revisions)
- Effect:Déjà vu (2 revisions)
- Finasteride (2 revisions)
- Effect:Neurogenesis (2 revisions)
- Effect:Dizziness (2 revisions)
- Omeprazole (2 revisions)